Latest filing published 02 Jul 2020 for Fusion Pharmaceuticals Inc., €3.6M.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Johan Christenson: trading record in brief
Johan Christenson has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Aprea Therapeutics, Inc. and Fusion Pharmaceuticals Inc. We count 6 filings; the first trade dates from 7 October 2019 and the latest from 30 June 2020.
The open-market record is one-sided, with 2 purchases worth €7.3M and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2020, the count stands at 1 purchase and no sales.
The newest entry dates from 2 July 2020: an open-market purchase of €3.6M, in Fusion Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Johan Christenson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 240,000 shares@ US$17.00100.0% of flowCommon SharesSEC:0000899243-20-018257:2Canonical exit: 28 Sept 2020 (T+90)
- 1,069,902 sharesCommon SharesSEC:0000899243-20-018257:1
- 2,497,345 sharesCommon SharesSEC:0000899243-20-018257:0
- 1,661,382 sharesCommon StockSEC:0001140361-19-018087:0
- 427,496 sharesCommon StockSEC:0001140361-19-018087:1
- 266,667 shares@ US$15.00Common StockSEC:0001140361-19-018087:2Canonical exit: 5 Jan 2020 (T+90)
6 of 6 declarations